These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7086650)

  • 21. Pharmacokinetics of sulfisoxazole compared in humans and two monogastric animal species.
    Suber RL; Lee C; Torosian G; Edds GT
    J Pharm Sci; 1981 Sep; 70(9):981-4. PubMed ID: 6101167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and interactions of digoxin with phenobarbital in dogs.
    Ravis WR; Pedersoli WM; Turco JD
    Am J Vet Res; 1987 Aug; 48(8):1244-9. PubMed ID: 3631715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relative absorption and elimination of sulfisoxazole and acetyl sulfisoxazole.
    LOUGHLIN EH; MULLIN WG
    Antibiot Chemother (Northfield); 1955 Nov; 5(11):609-15. PubMed ID: 24543797
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of diphenylhydantoin and its main hydroxylated metabolite on the pharmacokinetics and the urinary and biliary excretion of phenobarbital and its p-hydroxy metabolite.
    Sarhan F; Engasser JM; Batt AM; Magdalou J; Siest G
    Eur J Drug Metab Pharmacokinet; 1981; 6(2):99-108. PubMed ID: 7306277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intraindividual variations in the elimination rate of drugs].
    Krauer B
    Z Kinderheilkd; 1970; 108(3):231-7. PubMed ID: 5475033
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of morphine or phenobarbital on teicoplanin elimination pharmacokinetics.
    Fan-Havard P; Koshy Z; Bais RM; Smith C; Eng RH
    J Antimicrob Chemother; 1993 Jul; 32(1):101-8. PubMed ID: 8226400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Elimination kinetics of two sulfonamides in children with and without phenobarbital medication; a comparative study].
    Krauer B
    Schweiz Med Wochenschr; 1971 May; 101(19):668-71. PubMed ID: 5142850
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacokinetic modeling of the anticonvulsant action of phenobarbital in rats.
    Dingemanse J; van Bree JB; Danhof M
    J Pharmacol Exp Ther; 1989 May; 249(2):601-8. PubMed ID: 2724142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation between renal and hepatic excretion of drugs. XII. Influence of dexamethasone, triiodothyronine, or phenobarbital on the elimination of sulfonamides in rats of different ages.
    Fleck C; Nguyen Trong T; Bräunlich H
    Exp Pathol; 1989; 36(1):43-52. PubMed ID: 2731589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new sulfonamide, gantrisin; studies on solubility, absorption and excretion.
    SVEC FA; RHOADS PS; ROHR JH
    Arch Intern Med (Chic); 1950 Jan; 85(1):83-90. PubMed ID: 15408488
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacokinetics of trimethoprim in the rat.
    Tu YH; Allen LV; Fiorica VM; Albers DD
    J Pharm Sci; 1989 Jul; 78(7):556-60. PubMed ID: 2778654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of sulfisoxazole in young and elderly subjects.
    Boisvert A; Barbeau G; Bélanger PM
    Gerontology; 1984; 30(2):125-31. PubMed ID: 6706125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of pH on the accumulation of sulfonamides by fish.
    Lo IH; Hayton WL
    J Pharmacokinet Biopharm; 1981 Aug; 9(4):443-59. PubMed ID: 7310643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling the metabolism of idarubicin to idarubicinol in rat heart: effect of rutin and phenobarbital.
    Kang W; Weiss M
    Drug Metab Dispos; 2003 Apr; 31(4):462-8. PubMed ID: 12642473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Studies on the metabolism of sulfisoxazole. IV. Determination of sulfisoxazole in blood and its absorption].
    UNO T; KONO M; KONDO H
    Yakugaku Zasshi; 1961 Oct; 81():1509-11. PubMed ID: 13923833
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative pharmacokinetics of coumarin anticoagulants. XLVI: Effect of treatment of phenobarbital on pharmacokinetics of (S)-(-)-warfarin in rats.
    Yacobi A; Slattery JT; Levy G
    J Pharm Sci; 1980 Jun; 69(6):634-6. PubMed ID: 7205571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of butalbital and phenobarbital pretreatment on antipyrine clearance in the rat.
    Tse FL; Chang T; Jaffe JM
    Arch Int Pharmacodyn Ther; 1986 Feb; 279(2):181-94. PubMed ID: 3963935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of obesity on sulfonamide disposition in Zucker rats.
    Kaul S; Ritschel WA
    Eur J Drug Metab Pharmacokinet; 1988; 13(4):273-83. PubMed ID: 3243323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GI drug absorption in rats exposed to cobalt-60 gamma-radiation II: in vivo rate of absorption.
    Brady ME; Hayton WL
    J Pharm Sci; 1977 Mar; 66(3):366-70. PubMed ID: 845803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenobarbital in the genetically obese Zucker rat. I. Pharmacokinetics after acute and chronic administration.
    Brouwer KL; Kostenbauder HB; McNamara PJ; Blouin RA
    J Pharmacol Exp Ther; 1984 Dec; 231(3):649-53. PubMed ID: 6502518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.